Form 8-K - Current report:
SEC Accession No. 0001808665-21-000078
Filing Date
2021-11-04
Accepted
2021-11-04 16:08:01
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asrt-20211104.htm   iXBRL 8-K 41135
2 EX-99.1 asrt3q2021earningsreleasee.htm EX-99.1 258559
6 GRAPHIC image0a06a.jpg GRAPHIC 3999
  Complete submission text file 0001808665-21-000078.txt   471291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20211104.xsd EX-101.SCH 1980
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20211104_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20211104_pre.xml EX-101.PRE 13119
7 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20211104_htm.xml XML 11331
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 211379956
SIC: 2834 Pharmaceutical Preparations